What is ENVB's current stock price?

ENVB (Enveric Biosciences, Inc.) is currently trading at $2.21 with a market cap of $1.3M.

What sector is Enveric Biosciences, Inc. in?

Enveric Biosciences, Inc. (ENVB) operates in the Healthcare sector, specifically in the Biotechnology industry.

InvestLog

ENVB Enveric Biosciences, Inc.

Healthcare

$2.21-0.45%ClosedMarket Cap: $1.3M

As of 2026-05-25

Valuation

View Details

P/E (TTM)

—

PEG

—

P/B

0.66

P/S

0.00

EV/EBITDA

0.45

DCF Value

$12.40

FCF Yield

-606.9%

Div Yield

0.0%

Margins & Returns

Gross Margin

0.0%

Operating Margin

0.0%

Net Margin

0.0%

ROE

-221.0%

ROA

-148.9%

ROIC

-162.4%

Financials

View All

Period	Revenue	Net Income	EPS
Q1 null	$0.00	$-1.6M	$—
Q4 null	$0.00	$-2.2M	$—
FY null	$0.00	$-12.1M	$—
Q3 null	$0.00	$-1.9M	$—

Analyst Ratings

View All

Consensus

Buy

Target (Consensus)

$—

Target (Median)

$—

Target Range

$— - $—

1 Strong Buy0 Buy0 Hold0 Sell0 Strong Sell

Trading Activity

Insider Trades

View All

WEBB MICHAEL Ddirector

SellTue Dec 30

Tucker Joseph Edwarddirector, officer: Chief Executive Officer

SellTue Dec 30

Schabacker Marcusdirector

SellTue Dec 30

PASQUALONE FRANKdirector

SellTue Dec 30

Kegler George A.director

SellTue Dec 30

Latest News

Enveric Biosciences Reports Financial Results and Provides Corporate Update for Fourth Quarter and Fiscal Year Ended 2025Business Wire · Fri Mar 27

Company Info

Sector

Healthcare

Industry

Biotechnology

Country

Exchange

—

Beta

1.23

Enveric Biosciences, Inc., a pharmaceutical company, engages in developing various cannabinoid medicines for cancer care. Its products pipeline includes EV104 for the treatment of osteoarthritis; EVM-101 and EVM-201 for the treatment of cancer related distress; EVM-301 for the treatment of mental health indication; EV102, a cannabinoid cream for topical skin application; and EV101, a cannabinoid and chemotherapy combination therapy. Enveric Biosciences, Inc. is headquartered in Naples, Florida.

Peers